Researcher

Colin Stewart has established an international reputation in stem cells and mouse models of disease. His current research programme is on studying a collection of rare diseases (the laminopathies) that are relevant to understanding and developing new therapies for more common ailments, including heart failure, obesity and ageing. In 2012 he made a key discovery that loss of the protein SUN1 significantly ameliorated many of these diseases including heart failure and atherosclerosis. This has been the basis for him being a co-founder of Nuevocor, a Singapore company that is developing new therapeutics to treat these diseases, including novel forms of gene therapy.